Skip to content

Drug interactions

Flibanserin + Rucaparib

Severity: Moderate

Flibanserin and Rucaparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a weak-to-moderate inhibitor of CYP3A4 and CYP2C19, both involved in flibanserin metabolism. Flibanserin concentrations may rise, increasing hypotension, syncope and sedation.

What this interaction means in plain words

Flibanserin and Rucaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Flibanserin belongs to Genitourinary; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 and CYP2C19 metabolism of flibanserin by rucaparib.

What to do

Monitor for dizziness, hypotension and sedation, and advise caution with driving; consider flibanserin dose review if symptoms occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Flibanserin and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Flibanserin with Rucaparib?

MediHelp rates the interaction as moderate. Flibanserin and Rucaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rucaparib is a weak-to-moderate inhibitor of CYP3A4 and CYP2C19, both involved in flibanserin metabolism. Flibanserin concentrations may rise, increasing hypotension, syncope and sedation.

How serious is the interaction between Flibanserin and Rucaparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for dizziness, hypotension and sedation, and advise caution with driving; consider flibanserin dose review if symptoms occur.

What other medicines interact with Flibanserin?

MediHelp also lists interactions of Flibanserin with, for example, Atazanavir, Ceritinib, Clarithromycin. The full list is on the Flibanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in